NFKB1 and primary central nervous system lymphoma: The results of gene and transcriptome sequencing studies suggest that the oncogenic hallmark of PCNSL is the abnormal activation of the nuclear factor-kappa B (NF-κB) signaling pathway, which regulates B-cell proliferation, survival, differentiation, and cytokine expression (12, 13).